Patents by Inventor Alphonse Langlois

Alphonse Langlois has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Nucleic acids encoding DP-178 and other viral fusion inhibitor peptides useful for treating aids
    Publication number: 20070202127
    Abstract: The present invention relates to peptides which exhibit potent anti-retroviral activity. The peptides of the invention comprise DP178 (SEQ ID:1) peptide corresponding to amino acids 638 to 673 of the HIV-1LAI gp41 protein, and fragments, analogs and homologs of DP178. The invention further relates to the uses of such peptides as inhibitory of human and non-human retroviral, especially HIV, transmission to uninfected cells.
    Type: Application
    Filed: September 28, 2006
    Publication date: August 30, 2007
    Inventors: Dani Bolognesi, Thomas Matthews, Carl Wild, Shawn Barney, Dennis Lambert, Stephen Petteway, Alphonse Langlois
  • Methods and compositions for inhibition of membrane fusion-associated events, including HIV transmission
    Publication number: 20070037141
    Abstract: The present invention relates to peptides which exhibit potent anti-retroviral activity. The peptides of the invention comprise DP178 (SEQ ID:1) peptide corresponding to amino acids 638 to 673 of the HIV-1LAI gp41 protein, and fragments, analogs and homologs of DP178. The invention further relates to the uses of such peptides as inhibitory of human and non-human retroviral, especially HIV, transmission to uninfected cells.
    Type: Application
    Filed: December 17, 2003
    Publication date: February 15, 2007
    Inventors: Darii Bolognesi, Thomas Matthews, Carl Wild, Shawn Barney, Dennis Lambert, Stephen Petteway, Alphonse Langlois